...
首页> 外文期刊>Cureus. >A Rare Instance of Simultaneous Infection with Disseminated Nocardia and Pulmonary Aspergillus in a Patient Receiving Treatment with Ibrutinib for Chronic Lymphocytic Leukemia
【24h】

A Rare Instance of Simultaneous Infection with Disseminated Nocardia and Pulmonary Aspergillus in a Patient Receiving Treatment with Ibrutinib for Chronic Lymphocytic Leukemia

机译:接受依鲁替尼治疗慢性淋巴细胞白血病的患者同时发生弥漫性诺卡氏菌和肺曲霉菌同时感染的罕见病例

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Disseminated Nocardia infections are a rare occurrence that typically occur in immunocompromised hosts. Chronic lymphocytic leukemia (CLL) is a hematologic malignancy which makes patients susceptible to infections through various mechanisms. The treatments for CLL also target immunologic pathways which can contribute to infections. Ibrutinib is a commonly utilized tyrosine kinase inhibitor for CLL which targets the Bruton tyrosine kinase pathway. Although it is generally well tolerated, patients sometimes experience infections while on this medication, however, opportunistic infections are unusual. We present a rare, fatal case of a patient who developed simultaneous infections with bronchopulmonary Aspergillus and disseminated Nocardiosis to the subcutaneous tissues, lymph nodes and central nervous system while on treatment with ibrutinib for CLL.
机译:弥漫性诺卡氏菌感染很少见,通常发生在免疫功能低下的宿主中。慢性淋巴细胞性白血病(CLL)是一种血液恶性肿瘤,使患者容易通过各种机制感染。 CLL的治疗还针对可能导致感染的免疫途径。依鲁替尼是一种针对CLL的常用酪氨酸激酶抑制剂,其靶向布鲁顿酪氨酸激酶途径。尽管通常耐受性良好,但患者在使用这种药物时有时会发生感染,但是机会性感染并不常见。我们介绍了一个罕见的致命病例,该患者在用依鲁替尼治疗CLL时同时发生支气管肺炎曲霉菌感染并向皮下组织,淋巴结和中枢神经系统扩散了诺卡氏病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号